Tecan Group AG (0QLN.L)
CHF 140.26
(-2.19%)
CHF 140.26
(-2.19%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 725.05 Million CHF | -6.61% |
| 2022 | 776.4 Million CHF | -2.98% |
| 2021 | 800.25 Million CHF | 110.33% |
| 2020 | 380.47 Million CHF | 35.54% |
| 2019 | 280.7 Million CHF | 14.45% |
| 2018 | 245.26 Million CHF | -3.38% |
| 2017 | 253.84 Million CHF | 1.91% |
| 2016 | 249.07 Million CHF | 24.04% |
| 2015 | 200.8 Million CHF | 5.1% |
| 2014 | 191.06 Million CHF | 46.47% |
| 2013 | 130.44 Million CHF | 10.12% |
| 2012 | 118.46 Million CHF | -1.79% |
| 2011 | 120.62 Million CHF | 9.2% |
| 2010 | 110.46 Million CHF | -24.18% |
| 2009 | 145.68 Million CHF | -12.59% |
| 2008 | 166.67 Million CHF | -1.57% |
| 2007 | 169.33 Million CHF | -6.84% |
| 2006 | 181.76 Million CHF | -6.63% |
| 2005 | 194.67 Million CHF | 100.59% |
| 2004 | 97.05 Million CHF | -14.59% |
| 2003 | 113.62 Million CHF | 65.67% |
| 2002 | 68.58 Million CHF | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q2 | 710.16 Million CHF | 0.0% |
| 2023 Q4 | 725.05 Million CHF | 0.0% |
| 2023 FY | 725.05 Million CHF | -6.61% |
| 2023 Q2 | 710.8 Million CHF | 0.0% |
| 2022 FY | 776.4 Million CHF | -2.98% |
| 2022 Q4 | 776.4 Million CHF | 0.0% |
| 2022 Q2 | 778.72 Million CHF | 0.0% |
| 2021 FY | 800.25 Million CHF | 110.33% |
| 2021 Q4 | 800.25 Million CHF | 0.0% |
| 2021 Q2 | 341.27 Million CHF | 0.0% |
| 2020 Q4 | 380.47 Million CHF | 0.0% |
| 2020 Q2 | 292.6 Million CHF | 0.0% |
| 2020 FY | 380.47 Million CHF | 35.54% |
| 2019 Q4 | 280.7 Million CHF | 0.0% |
| 2019 Q2 | 287.43 Million CHF | 0.0% |
| 2019 FY | 280.7 Million CHF | 14.45% |
| 2018 Q4 | 245.26 Million CHF | 0.0% |
| 2018 FY | 245.26 Million CHF | -3.38% |
| 2018 Q2 | 232.42 Million CHF | 0.0% |
| 2017 Q4 | 253.84 Million CHF | 0.0% |
| 2017 Q2 | 238.38 Million CHF | 0.0% |
| 2017 FY | 253.84 Million CHF | 1.91% |
| 2016 FY | 249.07 Million CHF | 24.04% |
| 2016 Q4 | 249.07 Million CHF | 0.0% |
| 2016 Q2 | 222.88 Million CHF | 0.0% |
| 2015 Q4 | 200.8 Million CHF | 0.0% |
| 2015 Q2 | 168.9 Million CHF | 0.0% |
| 2015 FY | 200.8 Million CHF | 5.1% |
| 2014 Q4 | 191.06 Million CHF | 0.0% |
| 2014 Q2 | 138.45 Million CHF | 0.0% |
| 2014 FY | 191.06 Million CHF | 46.47% |
| 2013 FY | 130.44 Million CHF | 10.12% |
| 2013 Q4 | 130.44 Million CHF | 0.0% |
| 2013 Q2 | 122.92 Million CHF | 0.0% |
| 2012 FY | 118.46 Million CHF | -1.79% |
| 2012 Q4 | 118.46 Million CHF | 0.0% |
| 2012 Q2 | 114.9 Million CHF | 0.0% |
| 2011 FY | 120.62 Million CHF | 9.2% |
| 2011 Q4 | 120.62 Million CHF | 0.0% |
| 2011 Q2 | 112.87 Million CHF | 0.0% |
| 2010 FY | 110.46 Million CHF | -24.18% |
| 2010 Q2 | 102.03 Million CHF | 0.0% |
| 2010 Q4 | 110.46 Million CHF | 0.0% |
| 2009 Q4 | 145.68 Million CHF | 0.0% |
| 2009 FY | 145.68 Million CHF | -12.59% |
| 2008 FY | 166.67 Million CHF | -1.57% |
| 2007 FY | 169.33 Million CHF | -6.84% |
| 2006 FY | 181.76 Million CHF | -6.63% |
| 2005 FY | 194.67 Million CHF | 100.59% |
| 2004 FY | 97.05 Million CHF | -14.59% |
| 2003 FY | 113.62 Million CHF | 65.67% |
| 2002 FY | 68.58 Million CHF | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Relief Therapeutics Holding AG | 24.16 Million CHF | -2900.811% |
| Santhera Pharmaceuticals Holding AG | 49.68 Million CHF | -1359.276% |
| Basilea Pharmaceutica AG | 183.29 Million CHF | -295.574% |
| Bachem Holding AG | 362.35 Million CHF | -100.094% |
| Siegfried Holding AG | 1.02 Billion CHF | 29.15% |
| Molecular Partners AG | 21.92 Million CHF | -3207.285% |